BPH Global Ltd Asset Resilience Ratio
BPH Global Ltd asset resilience ratio. BPH Global Ltd (BP8) has an Asset Resilience Ratio of 33.28% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can BPH Global Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of BPH Global Ltd (2016–2023)
Asset resilience ratio of BPH Global Ltd from 2016 to 2023. This chart shows how BPH Global Ltd's Asset Resilience Ratio has changed over time. Read BPH Global Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down BPH Global Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BPH Global Ltd asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$630.00K | 33.28% |
| Total Liquid Assets | AU$630.00K | 33.28% |
Asset Resilience Insights
- Very High Liquidity: BPH Global Ltd maintains exceptional liquid asset reserves at 33.28% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BPH Global Ltd Industry Peers by Asset Resilience Ratio
Compare BPH Global Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
Drug Manufacturers - Specialty & Generic | 5.92% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Alembic Pharmaceuticals Limited
NSE:APLLTD |
Drug Manufacturers - Specialty & Generic | 0.14% |
|
Eris Lifesciences Limited
NSE:ERIS |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Guobang Pharma Ltd
SHG:605507 |
Drug Manufacturers - Specialty & Generic | 9.44% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
BPH Global Ltd Asset Resilience Ratio by Year (2016–2023)
BPH Global Ltd asset resilience ratio by year from 2016 to 2023. The table below shows the annual Asset Resilience Ratio data for BPH Global Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 29.99% | AU$630.83K ≈ $446.35K |
AU$2.10 Million ≈ $1.49 Million |
+20.99pp |
| 2022-06-30 | 8.99% | AU$685.56K ≈ $485.08K |
AU$7.62 Million ≈ $5.39 Million |
-47.94pp |
| 2021-06-30 | 56.93% | AU$5.26 Million ≈ $3.72 Million |
AU$9.23 Million ≈ $6.53 Million |
-28.68pp |
| 2020-06-30 | 85.61% | AU$866.83K ≈ $613.34K |
AU$1.01 Million ≈ $716.46K |
+7.41pp |
| 2019-06-30 | 78.19% | AU$1.90 Million ≈ $1.35 Million |
AU$2.43 Million ≈ $1.72 Million |
+9.51pp |
| 2018-06-30 | 68.69% | AU$1.09 Million ≈ $768.68K |
AU$1.58 Million ≈ $1.12 Million |
+29.01pp |
| 2017-06-30 | 39.67% | AU$1.04 Million ≈ $739.09K |
AU$2.63 Million ≈ $1.86 Million |
+39.32pp |
| 2016-06-30 | 0.35% | AU$17.14K ≈ $12.13K |
AU$4.88 Million ≈ $3.45 Million |
-- |
About BPH Global Ltd
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more